Want to see GLUE full AI Analyst Report?
Monte Rosa Therapeutics (GLUE) Ownership Overview
8.88% Insiders
17.37% Mutual Funds
0.31% Other Institutional Investors
15.65% ETFs
57.79% Public Companies and
Individual Investors
The ownership structure of Monte Rosa Therapeutics (GLUE) stock is a mix of institutional, retail, and individual investors. Approximately 33.33% of the company’s stock is owned by Institutional Investors, 8.88% is owned by Insiders, and 57.79% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jul 17, 2026 | xxxxxxxxxxxxx | $220210 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $231100 | |
May 22, 2026 | xxxxxxxxxxxxx | $180100 | |
Apr 15, 2026 | xxxxxxxxxxxxx | $141120 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $8797184 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $23301793 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $7201920 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,692,298 | Insider | 7.84% | 72,009,126 | |
| 4,345,736 | Institution | 5.09% | 46,760,119 | |
| 4,072,686 | Institution | 4.77% | 43,822,101 | |
| 3,572,670 | Institution | 4.19% | 38,441,929 | |
| 3,335,838 | Institution | 3.91% | 35,893,617 | |
| 3,180,780 | Institution | 3.73% | 34,225,193 | |
| 2,490,263 | Institution | 2.92% | 26,795,230 | |
| 2,232,091 | Institution | 2.62% | 24,017,299 | |
| 1,823,210 | Institution | 2.14% | 19,617,740 | |
| 1,555,664 | Institution | 1.82% | 16,738,945 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,335,838 | Institution | 3.91% | 35,893,617 | |
| 2,232,091 | Institution | 2.62% | 24,017,299 | |
| 1,823,210 | Institution | 2.14% | 19,617,740 | |
| 1,538,053 | Institution | 1.80% | 16,549,450 | |
| 889,302 | Institution | 1.04% | 9,568,890 | |
| 844,617 | Institution | 0.99% | 9,088,079 | |
| 559,325 | Institution | 0.66% | 6,018,337 | |
| 533,079 | Institution | 0.62% | 5,735,930 | |
| 511,389 | Institution | 0.60% | 5,502,546 | |
| 407,016 | Institution | 0.48% | 4,379,492 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,561,366 | Institution | 3.00% | 30,557,096 | |
| 2,218,097 | Institution | 2.60% | 24,066,352 | |
| 1,864,620 | Institution | 2.19% | 20,231,127 | |
| 837,291 | Institution | 0.98% | 9,988,882 | |
| 697,286 | Institution | 0.82% | 7,579,499 | |
| 463,816 | Institution | 0.54% | 5,041,680 | |
| 445,869 | Institution | 0.52% | 4,837,679 | |
| 430,676 | Institution | 0.50% | 5,137,965 | |
| 392,538 | Institution | 0.46% | 4,259,037 | |
| 381,882 | Institution | 0.45% | 4,143,420 |
FAQ
Who Owns Monte Rosa Therapeutics (GLUE)?
According to the latest TipRanks data, approximately 0.31% of the company's stock is held by institutional investors, 8.88% is held by insiders, and 57.79% is held by retail investors.
What percentage of Monte Rosa Therapeutics (GLUE) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.31% of Monte Rosa Therapeutics (GLUE) stock is held by institutional investors.
What percentage of Monte Rosa Therapeutics (GLUE) stock is held by retail investors?
According to the latest TipRanks data, approximately 57.79% of Monte Rosa Therapeutics (GLUE) stock is held by retail investors.
Who owns the most shares of Monte Rosa Therapeutics (GLUE)?
Ali Behbahani owns the most shares of Monte Rosa Therapeutics (GLUE).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.